Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
September 13, 2023
September 13, 2023
SANTA CLARA, California, Sept. 13 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release:
Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced they have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences. Financial terms of the agreement were not disclo . . .
Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced they have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences. Financial terms of the agreement were not disclo . . .